TriSalus Life Sciences • TLSI
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Ms. Mary T. Szela$281.4M
Market Cap • 26/04/20242020
(há 4 anos)
2023
(1 year ago)
NASDAQ
Listagem
Westminster
Sede • ColoradoValuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
TLSISó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.